CoChat

Cuprizone feed formulation influences the extent of demyelinating disease pathology

Open access
Toomey, Lillian M., Papini, Melissa, Lins, Brittney, Wright, Alexander J., Warnock, Andrew, McGonigle, Terence, Hellewell, Sarah C., Bartlett, Carole A., Anyaegbu, Chidozie, Fitzgerald, Melinda · 2021 · Scientific Reports
Cited by 49

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.

Abstract

Cuprizone is a copper-chelating agent that induces pathology similar to that within some multiple sclerosis (MS) lesions. The reliability and reproducibility of cuprizone for inducing demyelinating disease pathology depends on the animals ingesting consistent doses of cuprizone. Cuprizone-containing pelleted feed is a convenient way of delivering cuprizone, but the efficacy of these pellets at inducing demyelination has been questioned. This study compared the degree of demyelinating disease pathology between mice fed cuprizone delivered in pellets to mice fed a powdered cuprizone formulation at an early 3 week demyelinating timepoint. Within rostral corpus callosum, cuprizone pellets were more effective than cuprizone powder at increasing astrogliosis, microglial activation, DNA damage, and decreasing the density of mature oligodendrocytes. However, cuprizone powder demonstrated greater protein nitration relative to controls. Furthermore, mice fed control powder had significantly fewer mature oligodendrocytes than those fed control pellets. In caudal corpus callosum, cuprizone pellets performed better than cuprizone powder relative to controls at increasing astrogliosis, microglial activation, protein nitration, DNA damage, tissue swelling, and reducing the density of mature oligodendrocytes. Importantly, only cuprizone pellets induced detectable demyelination compared to controls. The two feeds had similar effects on oligodendrocyte precursor cell (OPC) dynamics. Taken together, these data suggest that demyelinating disease pathology is modelled more effectively with cuprizone pellets than powder at 3 weeks. Combined with the added convenience, cuprizone pellets are a suitable choice for inducing early demyelinating disease pathology.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-021-01963-3

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 31 references

Cited by

See all 49

Metadata

Authors
Toomey, L. M., Papini, M., Lins, B., Wright, A. J., Warnock, A., McGonigle, T., Hellewell, S. C., Bartlett, C. A., Anyaegbu, C., & Fitzgerald, M.
Venue
Scientific Reports
Published
2021-11-19
Volume
11
Issue
1
Pages
22594-22594
ISSN
2045-2322 (ISSN-L)
OpenAlex
W3211513370
Cited by
49
References
31
FWCI
4.44
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cuprizone feed formulation influences the extent of demyelinating disease pathology. https://app.cochat.ai/papers/10.1038/s41598-021-01963-3
The paper
Toomey, L. M., Papini, M., Lins, B., Wright, A. J., Warnock, A., McGonigle, T., Hellewell, S. C., Bartlett, C. A., Anyaegbu, C., & Fitzgerald, M. (2021). Cuprizone feed formulation influences the extent of demyelinating disease pathology. Scientific Reports. https://doi.org/10.1038/s41598-021-01963-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.